Advertisement
Screener

GRAIL, Inc. (GRAL) Price / FCF

3.3 / 5 stars · 13/20 Roast Me

GRAIL, Inc. Price-FCF Ratio

The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • GRAIL, Inc. price-fcf ratio for the quarter ending 2026-06-30 was -10.29, a change of -5.3 year-over-year.
  • GRAIL, Inc. price-fcf ratio for the quarter ending 2026-03-31 was -7.27, a change of -5.34 year-over-year.
  • GRAIL, Inc. price-fcf ratio for the quarter ending 2025-12-31 was -11.51, a change of -10.47 year-over-year.
  • GRAIL, Inc. price-fcf ratio for the quarter ending 2025-09-30 was -6.48.
  • GRAIL, Inc. price-fcf ratio for fiscal 2026 was -10.29.
  • GRAIL, Inc. price-fcf ratio for fiscal 2025 was -11.51, a change of -10.47 from fiscal 2024.
  • GRAIL, Inc. price-fcf ratio for fiscal 2024 was -1.04.
Available history
2024-12-31 to 2026-06-30
Data captured

Historical Price-FCF Ratio

DatePrice-FCF RatioMarket capitalizationFree cash flow 12 month
2026-06-30-10.29$3.05B-$296.16M
2026-03-31-7.27$2.13B-$292.33M
2025-12-31-11.51$3.45B-$299.92M
2025-09-30-6.48$2.14B-$329.83M
2025-06-30-4.99$1.86B-$371.75M
2025-03-31-1.93$901.48M-$467.6M
2024-12-31-1.04$605M-$582.36M

Annual Price-FCF Ratio

DatePrice-FCF RatioMarket capitalizationFree cash flow 12 month
2026-06-30-10.29$3.05B-$296.16M
2025-12-31-11.51$3.45B-$299.92M
2024-12-31-1.04$605M-$582.36M

Similar stocks

Stock NameCountryMarket CapPE Ratio
RadNet, Inc. (RDNT)United States$5.611B-229.65
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70